Exciting Virtual Fireside Chat with Intelligent Bio Solutions
NEW YORK — Intelligent Bio Solutions Inc. (NASDAQ: INBS), a pioneering medical technology company specializing in rapid, non-invasive testing solutions, is thrilled to announce an upcoming virtual fireside chat featuring President & CEO Harry Simeonidis and CFO Spiro Sakiris. This engaging event will take place at 4:30 p.m. ET, providing a unique opportunity for investors and stakeholders to gain insights into the company’s recent advancements.
Engaging Discussion on Recent Developments
Participants in the chat will delve into the company’s latest clinical study results and its strategic path towards seeking FDA 510(k) submission. This interactive session is designed not only to inform but also to engage the audience, allowing attendees to pose their questions directly to the company’s leadership team. It’s an invaluable chance to understand the future direction of Intelligent Bio Solutions and its innovative projects.
Details You Need to Know
When and Where
The virtual fireside chat will be held on December 11, 2024, at 4:30 p.m. ET. Interested participants are encouraged to register beforehand to secure their spot in this informative session.
How to Participate
During the event, a Q&A segment will wrap up the call, providing a platform for audience interaction. A recording of the session will be accessible post-event on the company’s Investor Relations website, allowing those who could not attend to catch up on all the insights shared.
About Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc. (NASDAQ: INBS) is dedicated to revolutionizing medical testing through innovative, non-invasive screening solutions. Their flagship Intelligent Fingerprinting Drug Screening System leverages fingerprint sweat analysis, aiming to transform portable testing applications across various industries. This hygienic, cost-effective system screens for commonly abused substances in workplace settings, including opiates, cocaine, methamphetamine, and cannabis. The rapid collection and quick results—achieved in less than ten minutes—make it an essential tool for employers in safety-centric sectors.
This cutting-edge technology is finding its way into numerous customer segments outside the U.S. including construction, manufacturing, transportation, and drug treatment facilities. The company’s commitment to innovation is evident in its approach to testing, enhancing workplace safety through rapid detection.
Contact Information for Further Inquiries
General Inquiries
For more information about Intelligent Bio Solutions Inc., please reach out via email at info@ibs.inc. The team is eager to provide insights and answers to any questions.
Investor Relations
For media inquiries or further information regarding investor relations, contact Valter Pinto, Managing Director at KCSA Strategic Communications. You can reach him at (212) 896-1254 or via email at INBS@kcsa.com.
Frequently Asked Questions
What is the purpose of the virtual fireside chat?
The fireside chat aims to discuss recent clinical results, the path towards FDA submission, and engage with investors through a Q&A session.
How can I participate in the event?
Interested individuals should register for the event to receive details on how to join the discussion on December 11.
Will a recording of the fireside chat be available?
Yes, a recording will be accessible on Intelligent Bio Solutions’ Investor Relations website after the event concludes.
What innovative product does Intelligent Bio Solutions offer?
The company offers the Intelligent Fingerprinting Drug Screening System, which allows for rapid drug testing using fingerprint sweat analysis.
Who can I contact for more information about the company?
You can reach out to Intelligent Bio Solutions Inc. via email at info@ibs.inc for general inquiries or contact KCSA Strategic Communications for investor-related questions.
